CDK12 and Familial prostate cancer: In fact, CDK12-variant tumors display higher overall levels of T cell infiltrating lymphocytes and greater numbers of expanded T cell clones than other prostate cancer subtypes; furthermore, these tumors display also increased expression of some chemokines and their receptors [305].